Condition
Mild to Moderate Hypertension
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06423352Phase 1CompletedPrimary
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
NCT07297797Phase 2RecruitingPrimary
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
NCT05530512Not ApplicableRecruitingPrimary
Acupuncture Therapy and Hypertension
NCT01601470Phase 2CompletedPrimary
Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension
Showing all 4 trials